Loading…
Use of artificial intelligence chatbots in clinical management of immune-related adverse events
BackgroundArtificial intelligence (AI) chatbots have become a major source of general and medical information, though their accuracy and completeness are still being assessed. Their utility to answer questions surrounding immune-related adverse events (irAEs), common and potentially dangerous toxici...
Saved in:
Published in: | Journal for immunotherapy of cancer 2024-05, Vol.12 (5), p.e008599 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | BackgroundArtificial intelligence (AI) chatbots have become a major source of general and medical information, though their accuracy and completeness are still being assessed. Their utility to answer questions surrounding immune-related adverse events (irAEs), common and potentially dangerous toxicities from cancer immunotherapy, are not well defined.MethodsWe developed 50 distinct questions with answers in available guidelines surrounding 10 irAE categories and queried two AI chatbots (ChatGPT and Bard), along with an additional 20 patient-specific scenarios. Experts in irAE management scored answers for accuracy and completion using a Likert scale ranging from 1 (least accurate/complete) to 4 (most accurate/complete). Answers across categories and across engines were compared.ResultsOverall, both engines scored highly for accuracy (mean scores for ChatGPT and Bard were 3.87 vs 3.5, p |
---|---|
ISSN: | 2051-1426 2051-1426 |
DOI: | 10.1136/jitc-2023-008599 |